ArticleAging clinical and experimental research2025
Fr-AGILE: validation and reliability of a multidimensional and rapid frailty assessment tool in the Turkish elderly population.
Article in Aging clinical and experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWith the global aging population, the prevalence of frailty is increasing, making its timely and accurate identification critical for prevention. This study aimed to evaluate the reliability and validity of the Fr-AGILE scale—a rapid, multidimensional frailty assessment tool—for use in the Turkish geriatric population.
methodsA total of 101 individuals aged 65 and over who visited a geriatric outpatient clinic were enrolled. All participants were assessed using the Fr-AGILE scale, alongside the FRAIL and Clinical Frailty Score as reference standards.
resultsThe Fr-AGILE scale demonstrated a sensitivity of 71.4% and specificity of 94.1%. Its positive predictive value was 83.3%, and the negative predictive value was 56.1%. High inter-rater reliability was observed, with substantial agreement in the physical, mental, and nutritional domains, and excellent agreement in the socioeconomic domain. Internal consistency coefficients were strong across all domains. The Fr-AGILE score showed significant correlations with the FRAIL scale (r = 0.742), Clinical Frailty Score(r = 0.732), and Comprehensive Geriatric Assessment with an AUC of 0.906 for severe frailty (p < 0.001).
conclusionThe Fr-AGILE scale is a valid and reliable tool for rapid, multidimensional frailty assessment in older adults. It provides a practical and efficient method for identifying frailty across physical, mental, nutritional, and socioeconomic domains in Turkish geriatric patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.